Clinical research around the world is focused on helping patients with blood cancers like leukemia, lymphoma, and multiple myeloma to benefit from a new class of cancer treatments called immunotherapy. CAR T cells, monoclonal antibodies, cancer vaccines, and checkpoint blockade are bringing patients new treatment options.
In this webinar for patients and caregivers, Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for cancers of the blood.
This webinar was recorded Tuesday, October 3, 2017. The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis.
Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series.
